Retraction Note to: Design and surface modification of potential luminomagnetic nanocarriers for biomedical applications (Journal of Nanoparticle Research, (2010), 12, 4, (1211-1219), 10.1007/s11051-009-9801-0);Design and surface modification of potential luminomagnetic nanocarriers for biomedical applications

Journal of Nanoparticle Research

Volumn 12, Issue 4, 2010, Pages 1211-1219

  Dutta, Ranu K ^a   Sharma, Prashant K ^a   Pandey, Avinash C ^a  

^a UNIVERSITY OF ALLAHABAD   (India)

Author keywords

Bioimaging; Folic acid; Hyperthermia; Magnetic nanoparticles; Nanomedicine; Surface modification; Targeted drug delivery

Indexed keywords

BIOCOMPATIBILITY; CHELATION; CONTROLLED DRUG DELIVERY; FOURIER TRANSFORM INFRARED SPECTROSCOPY; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; II-VI SEMICONDUCTORS; MAGNETIC MATERIALS; MAGNETIC NANOPARTICLES; MEDICAL APPLICATIONS; MEDICAL NANOTECHNOLOGY; MOLECULAR IMAGING; ORGANIC ACIDS; OXIDE MINERALS; PRECIPITATION (CHEMICAL); REMANENCE; SURFACE TREATMENT; ZINC OXIDE;

BIO-IMAGING; BIOMEDICAL APPLICATIONS; COPRECIPITATION METHOD; DEVELOPMENT AND APPLICATIONS; FOLIC ACIDS; FOURIER TRANSFORM INFRARED; HYPERTHERMIA; VIBRATING SAMPLE MAGNETOMETER;

TARGETED DRUG DELIVERY;

FOLATE RECEPTOR; FOLIC ACID; IRON DERIVATIVE; NANOCARRIER; ZINC OXIDE;

ARTICLE; BIOCOMPATIBILITY; BIOMEDICINE; CELL SPECIFICITY; CONFORMATIONAL TRANSITION; DRUG DELIVERY SYSTEM; HYPERTHERMIC THERAPY; HYSTERESIS; IMAGING SYSTEM; INFRARED SPECTROSCOPY; LUMINESCENCE; MACROMOLECULE; MAGNETISM; NANOMEDICINE; PARTICLE SIZE; PRECIPITATION; PRIORITY JOURNAL; SURFACE PROPERTY; SYNTHESIS; TECHNIQUE; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 77955091208     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-021-05302-5     Document Type: Erratum

References (33)

1. Aktaş Y, Yemisci M, Andrieux K, Gürsoy RN, Alonso MJ, Megia EF, Carballal RN, Quinõá E, Riguera R, Sargon MF, Çelik HH, Demir AS, Hincal AA, Dalkara T, Çapan Y, Couvreur P (2005) Development and brain delivery of Chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26. Bioconjugate Chem 16(6):1503-1511
2. Alexiou C, Arnold W, Klein RJ, Parak FG, Hulin P, Bergemann C, Erhardt W, Wagenpfeil S, Lübbe AS (2000) Locoregional cancer treatment with magnetic drug targeting. Cancer Res 60:6641-6648
3. Bulte JW, Hoekstra Y, Kamman RL, Magin RL, Webb AG, Briggs RW, Go KG, Hulstaert CE, Miltenyi S, The TH (1992) Specific MR imaging of human lymphocytes by monoclonal antibody-guided dextran-magnetite particles. Magn Reson Med 25:148-157
4. Gabizon A, Horowitz AT, Goren D, Tzemach D, Mandelbaum-Shavit F, Qazen MM, Zalipsky S (1999) Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. Bioconjugate Chem 10:289-298
5. Jaffer FA, Weissleder R (2004) Seeing within: molecular imaging of the cardiovascular system. Circ Res 94:433-445
6. Keshari AK, Kumar M, Singh PK, Pandey AC (2007) Influenceof organic polymers as capping agent on structural and optical properties of ZnS:Mn2+ and CdS nanocrystals. J Nanosci Nanotechnol 8:1-4
7. Kim SH, Jeong JH, Chun KW, Park TG (2005) Target-specific cellular uptake of PLGA nanoparticles coated with poly(llysine)-poly(ethylene glycol)-folate conjugate. Langmuir 21(19):8852-8857
8. Kim IB, Shin H, Garcia AJ, Bunz UHF (2007) Use of a folate-PPE conjugate to image cancer cells in vitro. Bioconjugate Chem 18(3):815-820
9. Knauth M, Egelhof T, Roth SU, Wirtz CR, Sartor K (2001) Intraoperative MR imaging increases the extent of tumor resection in patients with high-grade gliomas. Am J Neuroradiol 22:99-102
10. Kohler N, Sun C, Wang J, Zhang M (2005) Methotrexatemodified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells. Langmuir 21(19):8858-8864
11. Kojima C, Kono K, Maruyama K, Takagishi T (2000) Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. Bioconjugate Chem 11:910-917
12. Leamon CP, Pastan I, Low PS (1993) Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain. J Biol Chem 268:24847-24854
13. Nayak S, Lee H, Chmielewski J, Lyon LA (2004) Folatemediatedcell targeting and cytotoxicity using thermoresponsive microgels. J Am Chem Soc 126(33):10258-10259
14. Nitin N, Javier DJ, Kortum RR (2007) Oligonucleotide-coated metallic nanoparticles as a flexible platform for molecular imaging agents. Bioconjugate Chem 18(6):2090-2096
15. Oh Eugene, Jung Seung-Ho, Lee Kun-Hong, Jeong Soo-Hwan, Yu SeGi, Rhee SeukJoo (2008) Vertically aligned Fedoped ZnO nanorod arrays by ultrasonic irradiation and their photoluminescence properties. Mater Lett 62:3456-3458
16. Oyewumi MO, Mumpe RJ (2002) Engineering tumor-targetedgadolinium hexanedione nanoparticles for potential application in neutron capture therapy. Bioconjugate Chem 13(6):1328-1335
17. Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP (2005) Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 338:284-293
18. Santra S, Tapec R, Theodoropoulou N, Dobson J, Hebard A, Tan W (2001) Synthesis and characterization of silicacoated iron oxide nanoparticles in microemulsion: the effect of nonionic surfactants. Langmuir 17:2900-2906
19. Schellenberger EA, Reynolds F, Weissleder R, Josephson L (2004) Surface-functionalized nanoparticle library yields probes for apoptotic cells. ChemBioChem 5:275-279
20. Seonghoon B, Jaejin S, Sangwoo L (2007) Improvement of the optical properties of ZnO nanorods by Fe doping. Physica B 399:101-104
21. 2 matrix. J Lumin 129:605-610
22. 2+ nanoparticles: synthesis and characterization for their applications in white light generation from UV LEDs, IEEE TNANO. Article ID: TNANO-00048-2009 (in press)
23. Sharma PK, Dutta RK, Pandey AC, Layek S, Verma HC (2009c) Effect of iron doping concentration on magnetic properties of ZnO nanoparticles. J Magn Magn Mater 321:2587-2591
24. Sirotnak FM, Tolner B (1999) Carrier-mediated membrane transport of folates in mammalian cells. Annu Rev Nutr 19:91-122
25. Stefflova K, Li H, Chen J, Zheng G (2007) Peptide-based pharmacomodulation of a cancer-targeted optical imaging and photodynamic therapy agent. Bioconjugate Chem 18(2):379-388
26. Stella B, Arpicco S, Peracchia MT, Desmaële D, Hoebeke J, Renoir M, D'Angelo J, Cattel L, Couvreur P (2000) Design of folic acid-conjugated nanoparticles for drug targeting. J Pharm Sci 89:1452-1464
27. Sudimack J, Lee RJ (2000) Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev 41:147-162
28. Voltairas PA, Fotiadis DI, Michalis LK (2002) Hydrodynamicsof magnetic drug targeting. J Biomech 35:813-821
29. Wilfried A, Nowak H (1998) Magnetism in medicine. Wiley- VCH, Weinheim, Germany
30. Xiong Y, Zhang LZ, Tang G, Zhang G, Chen WJ (2004) ZnO nanoparticles included within all-silica MCM-41: preparation and spectroscopic studies. J Lumin 110:17-22
31. Yang PH, Sun X, Chiu JF, Sun H, He QY (2005) Transferrinmediated gold nanoparticle cellular uptake. Bioconjugate Chem 16(3):494-496
32. Zhang N, Chittasupho C, Duangrat C, Siahaan TJ, Berkland C (2008a) PLGA nanoparticle#peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjugate Chem 19:145-152
33. Zhang B, Zhou SM, Wang HW, ZuLiang DU (2008b) Raman scattering and photoluminescence of Fe-doped ZnO nanocantilever arrays. Chin Sci Bull 53:1639-1643